Novogene is working with Mission Bio to offer customers in China access to the Tapestri Platform, which is being used in the drug development process by LabCorp and more than a dozen institutions.
Drug development advisory firm Rosa & Co. enters research agreement with Chugai pharmaceutical to provide access to PhysioPD research services for translational biology.
Recipham has agreed to pay the founders of Nitin Lifescience Limited INR2.8bn ($44m) for the remaining 26% stake they own in the India-based drug manufacturer.
Following its proposed LabAnswer acquisition, Accenture will form a scientific informatics service division, which it said will enable new patient treatments with “new insights into human biology.”
Thermo Fisher Scientific says it is buying Finesse Solutions, its long-term supplier of measurement and control solutions for bioprocessing applications.
EAG Laboratories has added 33,000-square-feet to its Easton, Maryland facility, with space for dedicated laboratories and equipment to support GLP-compliant ecotoxicology, environmental fate, metabolism, and other testing services.
Some drug industry sponsors shy away from “jack of all trades” contractors according to a recently formed UK CRO network which says smaller firms with specific expertise can win market share.
GE Healthcare has pledged its support and technology to a national £55m ($86m) Cell Therapy manufacturing centre in Stevenage, UK, set to launch in 2017.
Indian CRO GVK BIO announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment CRO operating out of Chennai, India.
in-PharmaTechnologist.com presents its latest round up of executive moves in the pharma sector, including appointments at Sanofi, Amylin, Lophius Biosciences, Lophius, Adventrx, BioSante and Medicure.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB.
Bayer HealthCare is investing €35m ($47m) in a new centre for the biotechnological production of ‘innovative’ pharmaceuticals to be used in clinical trials.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Pfizer and AstraZeneca naming R&D leaders and appointments at APV and Lonza.
Lonza has reported stronger demand in the first quarter, but volatility remains in the custom manufacturing sector and it is uncertain if improvements “represent true and full economic recovery”.
Contract research organisation (CRO) Ricerca Biosciences has entered into a business development deal with Japan-based Life Science Partner (LSP) to help penetrate the Asian market.
Environmental laboratory Alpha Analytical has expanded into the life sciences sector by acquiring CRO Boston Analytical and is now targeting the Massachusetts, US biotech sector, its president told Outsourcing-Pharma.
DHL Global Forwarding has opened a Life Science Competency Center in Carolina, Puerto Rico, which will offer shipping services tailored to the needs of the island’s biotech and pharmaceutical companies.
US-based BioDuro and The National Center for Safety Evaluation of
Drugs (NCSED) in Beijing have received full accreditation from the
Association for Assessment and Accreditation of Laboratory Animal
Care International (AAALAC).
Microarray expert Affymetrix is to buy molecular biology reagent
firm USB Corporation for $75m (€52m) in a bid to accelerate the
development of new genetic analysis tools.
In this week's review of activity within the preclinical research
services arena, new deals have emerged involving Gene Bridges,
Panacos Pharmaceuticals, and GenScript.
Clariant has cut its ties with the life sciences industry and will
no longer offer custom manufacturing services in this arena after
the sale of the last piece of its Lifesciences division.
Tripos has launched new software that allows scientists to access
and analyse chemical and biological data from a single integrated
desktop discovery environment
Surmodics has announced that as a result of a collaboration with
the Donaldson Company, the first of a collection of new synthetic
nanofibrillar cell culture surfaces have been produced that will
improve cell culture, cell-based bioassays...
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
Filtration system Pall Corporation reported its first quarter
earnings which revealed earnings rose by 16 per cent, propelled by
growth in its industrial and biopharmaceuticals segments.
An affirmation that aims to replace the use of laboratory animals
in testing was agreed in Brussels by key industry sectors
representing the European chemical, pharmaceutical and
biotechnology industries.
Life sciences is to be given priority under a European Commission
(EU) framework, which focuses on creating a knowledge-based economy
to ensure increased funding for this industry.
Invitrogen has announced two additional acquisitions in the area of
nanotechnologcal tools for target and drug discovery, just as it
completes the earlier-announced purchase of Biosource
International.
Teranode Corporation has launched new screening automation software
that claims to be the first ever solution to transform assay design
into assay automation - a tool that is to feature heavily for
screening laboratories with changing...
EMBiology, an online resource launched this week, aims to become
the main research library for pharmaceutical and biotechnology
companies, reports Ahmed ElAmin.
Genevac has launched a brand new evaporation system aimed at the
molecular biology market. The technology marks a significant
departure for the company as its products have been focussed on
drug discovery chemistry until now.
Magellan Biosciences' expressed interest in the life science,
research and clinical diagnostics market turned to action after the
life sciences company confirmed the acquisition of Dynex
Technologies.
Serologicals has completed its acquisition of Upstate Group,
acquiring the privately held company for $205 million (€166m) in
cash ($102.5m) and stock.
US life science company Serologicals has entered into a €167.6
million merger with cell signallin specialist Upstate, creating a
significant presence in the preclinical drug screening and target
validation market, the fastest growing...
LION bioscience has delayed the publication of its third-quarter
results after a change in its accounting procedures that will see
licence revenues spread across the term of the contracts, instead
of booked in the quarter they are...
German drug major Bayer has entered into a collaboration with
Artemis Pharmaceuticals focusing on the development of
genetically-engineered mice that are designed to have human-like
biology. The ArteMice will be used in Bayer's...
Industry-backed group says UK should help support the country's
biotech companies by setting up a national agency to organise
clinical trials and boost companies' liquidity.
